Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial (Q34150890)

31 July 2017

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial (English)

1 reference

31 July 2017

0 references

1 reference

3

Henry Krum

1 reference

ORCID Public Data File 2021

31 July 2017

1 reference

author name string

Symplicity HTN-2 Investigators

1

1 reference

31 July 2017

Murray D Esler

2

1 reference

31 July 2017

Paul A Sobotka

4

1 reference

31 July 2017

Markus P Schlaich

5

1 reference

31 July 2017

Roland E Schmieder

6

1 reference

31 July 2017

Michael Böhm

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

17 November 2010

1 reference

31 July 2017

1 reference

31 July 2017

376

1 reference

31 July 2017

1903-1909

1 reference

31 July 2017

9756

1 reference

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Hypertension treatment and control in five European countries, Canada, and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Neural control of renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Sympathetic nerve activity in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Functional role of renal afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

The effects of splanchnicectomy on the blood pressure in hypertension; a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Splanchnicectomy for essential hypertension; results in 1,266 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Renal sympathetic-nerve ablation for uncontrolled hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Translational medicine: the antihypertensive effect of renal denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Neural mechanisms in human obesity-related hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Renal afferent denervation prevents hypertension in rats with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Sympathetic overactivity in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

The transplanted human kidney does not achieve functional reinnervation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

Increased Sympathetic Nervous Activity and the Effects of Its Inhibition with Clonidine in Alcoholic Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962039-9

7 January 2021

10.1016/S0140-6736(10)62039-9

Identifiers

DOI

1 reference

31 July 2017

1 reference